Form 8-K · Current report
Equifax 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0000033185
- Accession no.
- 0001193125-26-323760
Summary
Equifax executed an underwriting agreement with J.P. Morgan Securities, BofA Securities, Truist Securities, and Wells Fargo Securities and issued $500 million of 5.000% senior notes due 2029 and $500 million of 5.650% senior notes due 2033. Equifax said it intends to use the approximately $990.5 million in net proceeds to repay borrowings under its commercial paper program.
Key points
- Equifax issued $500 million aggregate principal amount of 5.000% senior notes due 2029 and $500 million aggregate principal amount of 5.650% senior notes due 2033.
- The notes were issued under an indenture with U.S. Bank Trust Company, National Association as trustee.
- Net proceeds from the offering were approximately $990.5 million after underwriting discounts and estimated offering expenses.
- Equifax intends to use the net proceeds to repay borrowings under its commercial paper program.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01. Other Events. Public Offering of Senior Notes On July 22, 2026, Equifax Inc. (the “Company”) executed an Underwriting Agreement with J.P. Morgan Securities LLC, BofA Securities, Inc., Truist Securities, Inc. and Wells Fargo Securities, LLC, as the representatives of the underwriters named therein (the “Underwriting Agreement”), with regard to the issuance and sale by the Company of $500,000,000 aggregate principal amount of the Company’s 5.000% Senior Notes due 2029 (the “2029 Notes”) and $500,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2033 (the “2033 Notes” and, together with the 2029 Notes, the “Notes”). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.